Company Filing History:
Years Active: 2008
Title: **Catherine Ann Morrissey: Innovator in Pharmaceutical Formulations**
Introduction
Catherine Ann Morrissey, an accomplished inventor from County Westmeath, Ireland, has significantly contributed to the field of pharmaceuticals. Her innovative approach to drug formulation aims to enhance the effectiveness and accessibility of medications.
Latest Patents
Morrissey holds a patent for "Multiparticulate controlled release selective serotonin reuptake inhibitor formulations." This groundbreaking formulation allows for the oral administration of a multiparticulate controlled release SSRI, which is designed to release the active ingredient gradually over a minimum of 12 hours. The formulation incorporates particles coated with a rate-controlling polymer consisting of either a water-insoluble polymer or a combination of water-insoluble and water-soluble polymers. This innovation facilitates enhanced therapeutic effects while minimizing side effects.
Career Highlights
Catherine Ann Morrissey is affiliated with Elan Pharma International Limited, where she works alongside a talented team that includes coworkers Theresa Ann Jeary and Paul Stark. Her career has been marked by a focus on advancing pharmaceutical technologies that improve patient outcomes.
Collaborations
Throughout her career, Morrissey has engaged in meaningful collaborations with her colleagues at Elan Pharma International Limited. Working alongside experts in the field has allowed her to refine her inventions and contribute to the company's broader mission of enhancing drug delivery systems.
Conclusion
Catherine Ann Morrissey's contributions to pharmaceutical innovations highlight the importance of controlled release formulations in modern medicine. Her patent is a testament to her dedication and creativity as an inventor, and it has the potential to impact the pharmacological landscape significantly. Through her work, she exemplifies the role of inventors in transforming healthcare and improving lives.